vs
Side-by-side financial comparison of EVOLUTION PETROLEUM CORP (EPM) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
EVOLUTION PETROLEUM CORP is the larger business by last-quarter revenue ($20.7M vs $18.3M, roughly 1.1× ROCKWELL MEDICAL, INC.). EVOLUTION PETROLEUM CORP runs the higher net margin — 5.2% vs -3.0%, a 8.2% gap on every dollar of revenue. On growth, EVOLUTION PETROLEUM CORP posted the faster year-over-year revenue change (2.0% vs -25.6%). Over the past eight quarters, EVOLUTION PETROLEUM CORP's revenue compounded faster (-5.2% CAGR vs -10.1%).
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
EPM vs RMTI — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.7M | $18.3M |
| Net Profit | $1.1M | $-554.0K |
| Gross Margin | 44.3% | 21.1% |
| Operating Margin | 3.2% | -2.2% |
| Net Margin | 5.2% | -3.0% |
| Revenue YoY | 2.0% | -25.6% |
| Net Profit YoY | 158.4% | 26.7% |
| EPS (diluted) | $0.03 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.7M | $18.3M | ||
| Q3 25 | $21.3M | $15.9M | ||
| Q2 25 | $21.1M | $16.1M | ||
| Q1 25 | $22.6M | $18.9M | ||
| Q4 24 | $20.3M | $24.7M | ||
| Q3 24 | $21.9M | $28.3M | ||
| Q2 24 | $21.2M | $25.8M | ||
| Q1 24 | $23.0M | $22.7M |
| Q4 25 | $1.1M | $-554.0K | ||
| Q3 25 | $824.0K | $-1.8M | ||
| Q2 25 | $3.4M | $-1.5M | ||
| Q1 25 | $-2.2M | $-1.5M | ||
| Q4 24 | $-1.8M | $-756.0K | ||
| Q3 24 | $2.1M | $1.7M | ||
| Q2 24 | $1.2M | $343.0K | ||
| Q1 24 | $289.0K | $-1.7M |
| Q4 25 | 44.3% | 21.1% | ||
| Q3 25 | 38.5% | 14.3% | ||
| Q2 25 | 46.1% | 15.6% | ||
| Q1 25 | 40.7% | 16.1% | ||
| Q4 24 | 36.9% | 14.7% | ||
| Q3 24 | 46.2% | 22.0% | ||
| Q2 24 | 46.3% | 17.6% | ||
| Q1 24 | 45.2% | 13.5% |
| Q4 25 | 3.2% | -2.2% | ||
| Q3 25 | -0.4% | -9.9% | ||
| Q2 25 | 6.3% | -8.4% | ||
| Q1 25 | 7.0% | -7.2% | ||
| Q4 24 | -3.0% | -2.1% | ||
| Q3 24 | 8.5% | 6.8% | ||
| Q2 24 | 11.3% | 2.0% | ||
| Q1 24 | 9.1% | -5.8% |
| Q4 25 | 5.2% | -3.0% | ||
| Q3 25 | 3.9% | -11.0% | ||
| Q2 25 | 16.2% | -9.3% | ||
| Q1 25 | -9.7% | -8.0% | ||
| Q4 24 | -9.0% | -3.1% | ||
| Q3 24 | 9.4% | 5.9% | ||
| Q2 24 | 5.8% | 1.3% | ||
| Q1 24 | 1.3% | -7.6% |
| Q4 25 | $0.03 | $-0.01 | ||
| Q3 25 | $0.02 | $-0.05 | ||
| Q2 25 | $0.10 | $-0.05 | ||
| Q1 25 | $-0.07 | $-0.04 | ||
| Q4 24 | $-0.06 | $-0.02 | ||
| Q3 24 | $0.06 | $0.04 | ||
| Q2 24 | $0.04 | $0.01 | ||
| Q1 24 | $0.01 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.8M | $10.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $67.5M | $37.0M |
| Total Assets | $169.3M | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.8M | $10.7M | ||
| Q3 25 | $714.0K | $13.6M | ||
| Q2 25 | $2.5M | $12.5M | ||
| Q1 25 | $5.6M | $11.4M | ||
| Q4 24 | $11.7M | $15.7M | ||
| Q3 24 | $6.9M | $12.3M | ||
| Q2 24 | $6.4M | $11.9M | ||
| Q1 24 | $3.1M | $6.6M |
| Q4 25 | $67.5M | $37.0M | ||
| Q3 25 | $69.1M | $37.0M | ||
| Q2 25 | $71.8M | $30.4M | ||
| Q1 25 | $71.7M | $31.5M | ||
| Q4 24 | $76.3M | $32.6M | ||
| Q3 24 | $79.6M | $29.1M | ||
| Q2 24 | $81.1M | $23.5M | ||
| Q1 24 | $83.5M | $20.6M |
| Q4 25 | $169.3M | $57.1M | ||
| Q3 25 | $169.1M | $57.5M | ||
| Q2 25 | $160.3M | $52.6M | ||
| Q1 25 | $156.4M | $54.0M | ||
| Q4 24 | $160.2M | $59.2M | ||
| Q3 24 | $157.9M | $57.1M | ||
| Q2 24 | $162.9M | $53.0M | ||
| Q1 24 | $166.5M | $50.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.4M | $2.3M |
| Free Cash FlowOCF − Capex | — | $2.2M |
| FCF MarginFCF / Revenue | — | 12.0% |
| Capex IntensityCapex / Revenue | — | 0.5% |
| Cash ConversionOCF / Net Profit | 5.09× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.4M | $2.3M | ||
| Q3 25 | $7.8M | $-1.3M | ||
| Q2 25 | $10.5M | $1.8M | ||
| Q1 25 | $7.3M | $-3.5M | ||
| Q4 24 | $7.7M | $865.0K | ||
| Q3 24 | $7.6M | $4.3M | ||
| Q2 24 | $8.0M | $1.4M | ||
| Q1 24 | $3.4M | $-2.4M |
| Q4 25 | — | $2.2M | ||
| Q3 25 | — | $-1.5M | ||
| Q2 25 | — | $1.7M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | — | $470.0K | ||
| Q3 24 | — | $4.1M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $-2.5M |
| Q4 25 | — | 12.0% | ||
| Q3 25 | — | -9.6% | ||
| Q2 25 | — | 10.5% | ||
| Q1 25 | — | -18.8% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 14.4% | ||
| Q2 24 | — | 4.5% | ||
| Q1 24 | — | -11.1% |
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 1.4% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | 5.09× | — | ||
| Q3 25 | 9.47× | — | ||
| Q2 25 | 3.06× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.69× | 2.57× | ||
| Q2 24 | 6.47× | 4.20× | ||
| Q1 24 | 11.64× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EPM
| Crude Oil | $10.7M | 52% |
| Natural Gas Reserves | $7.4M | 36% |
| Natural Gas Liquids Reserves | $2.5M | 12% |
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
